| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,300 | 13,375 | 14,788 | 17,438 | | Cost of Revenue | 3,464 | 3,250 | 3,556 | 4,292 | | | Gross Profit | 10,836 | 10,125 | 11,232 | 13,146 | | | Operating Expenses | | Research Development | 6,149 | 2,790 | 3,261 | 3,902 | | Selling General and Administrative | 7,008 | 7,840 | 8,924 | 10,651 | | Non Recurring |
-
| 3,147 |
-
| 660 | | Others | (1,307) | 1,307 |
-
|
-
| | | | Total Operating Expenses |
-
| 15,084 |
-
|
-
| | | | Operating Income or Loss | (1,014) | (4,959) | (953) | (2,067) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 200 | 330 | 430 | 787 | | Earnings Before Interest And Taxes | (814) | (4,629) | (523) | (1,280) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (814) | (4,629) | (523) | (1,280) | | Income Tax Expense | (29,376) | 14,992 | (272) | (894) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,562 | (19,621) | (251) | (386) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (750) | (19,621) | (251) | (386) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($750) | ($19,621) | ($251) | ($386) |
|
0.51% Nasdaq 
0.02 (0.15%) 
Income Statement
